Neuroscience

Study finds multiple sclerosis drug slows brain shrinkage

Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side ...

Diabetes

Pioglitazone cuts diabetes risk after ischemic stroke, TIA

(HealthDay)—For insulin-resistant patients with recent ischemic stroke or transient ischemic attack, pioglitazone is associated with reduced risk of diabetes, according to a study published online July 27 in Diabetes Care.

page 7 from 40